Advanced in Splenomegaly

Dr. Elizabeth O. Hexner

Hematology
Perelman Center For Advanced Medicine
3400 Civic Center Boulevard, West Pavilion, 4th Floor, 
Philadelphia, PA 
Accepting New Patients
Offers Telehealth
26 Years of Experience
Advanced in Splenomegaly
Perelman Center For Advanced Medicine
3400 Civic Center Boulevard, West Pavilion, 4th Floor, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Elizabeth Hexner is a Hematologist in Philadelphia, Pennsylvania. Dr. Hexner has been practicing medicine for over 26 years and is rated as an Advanced provider by MediFind in the treatment of Splenomegaly. Her top areas of expertise are Systemic Mastocytosis, Graft Versus Host Disease (GvHD), Myelofibrosis, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Hexner is currently accepting new patients.

Her clinical research consists of co-authoring 147 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Splenomegaly.

Specialties
Hematology
Licenses
Internal Medicine in PA
Hospital Affiliations
Hospital Of Univ Of Pennsylvania
Pennsylvania Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Perelman Center for Advanced Medicine
3400 Civic Center Boulevard, West Pavilion, 4th Floor, Philadelphia, PA 19104
Call: 215-615-5858

Additional Areas of Focus

Dr. Hexner has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Myelofibrosis
Polycythemia Vera
Systemic Mastocytosis

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Open-label, Single Arm, Phase 2 Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis
An Open-label, Single Arm, Phase 2 Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Drug
Study Drug: Avapritinib
Study Phase: Phase 2
A Phase 1 Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies
A Phase 1 Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies
Enrollment Status: Completed
Publish Date: March 17, 2023
Intervention Type: Drug
Study Drug: Avapritinib
Study Phase: Phase 1
A Phase Ib Study of Ruxolitinib in Combination With PU-H71 for the Treatment of Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), and Post-EssentialThrombocythemia MF (Post-ET MF)
A Phase Ib Study of Ruxolitinib in Combination With PU-H71 for the Treatment of Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), and Post-EssentialThrombocythemia MF (Post-ET MF)
Enrollment Status: Terminated
Publish Date: November 15, 2022
Intervention Type: Drug
Study Phase: Phase 1
Open Label Phase I Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia (With Pilot Feasibility Study in Combination With Pegylated Interferon Alfa 2a for Patients Who do Not Respond to the Single Agent at Each Dose Level)
Open Label Phase I Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia (With Pilot Feasibility Study in Combination With Pegylated Interferon Alfa 2a for Patients Who do Not Respond to the Single Agent at Each Dose Level)
Enrollment Status: Completed
Publish Date: September 12, 2019
Intervention Type: Drug
Study Phase: Phase 1
Research Tissue Bank
Research Tissue Bank
Enrollment Status: Completed
Publish Date: July 05, 2019
Multicenter Phase I/II Trial of Ruxolitinib in Combination With Decitabine in Patients With Accelerated Phase Myeloproliferative Neoplasm (MPN) or Post-MPN AML
Multicenter Phase I/II Trial of Ruxolitinib in Combination With Decitabine in Patients With Accelerated Phase Myeloproliferative Neoplasm (MPN) or Post-MPN AML
Enrollment Status: Completed
Publish Date: February 28, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Correlative Biomarker Study for MPD-RC Treatment Studies in the Philadelphia Chromosome Negative MPD
Correlative Biomarker Study for MPD-RC Treatment Studies in the Philadelphia Chromosome Negative MPD
Enrollment Status: Completed
Publish Date: December 13, 2018
View 6 Less Clinical Trials

146 Total Publications

Enhanced CAR T-Cell Therapy for Relapsed Lymphoma. Reply.
Enhanced CAR T-Cell Therapy for Relapsed Lymphoma. Reply.
Journal: The New England journal of medicine
Published: August 06, 2025
View All 146 Publications
Similar Doctors
Advanced in Splenomegaly
Dr. Cheryl A. Johnson
Hematology | Oncology
Advanced in Splenomegaly
Dr. Cheryl A. Johnson
Hematology | Oncology

Abramson Cancer Center Kennett Square

400 McFarlan Road, Suite 300, 
Kennett Square, PA 
 (27.3 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Cheryl Johnson is a Hematologist and an Oncologist in Kennett Square, Pennsylvania. Dr. Johnson is rated as a Distinguished provider by MediFind in the treatment of Splenomegaly. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Cervical Cancer, and Inflammatory Breast Cancer. Dr. Johnson is currently accepting new patients.

Advanced in Splenomegaly
Dr. Sunil Saroha
Hematology | Oncology
Advanced in Splenomegaly
Dr. Sunil Saroha
Hematology | Oncology

Abramson Cancer Center Kennett Square

400 McFarlan Road, Suite 300, 
Kennett Square, PA 
 (27.3 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sunil Saroha is a Hematologist and an Oncologist in Kennett Square, Pennsylvania. Dr. Saroha is rated as a Distinguished provider by MediFind in the treatment of Splenomegaly. His top areas of expertise are Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Idiopathic Neutropenia, and Thrombocytopenia. Dr. Saroha is currently accepting new patients.

Advanced in Splenomegaly
Dr. Robert K. Roush
Hematology Oncology | Hematology | Oncology
Advanced in Splenomegaly
Dr. Robert K. Roush
Hematology Oncology | Hematology | Oncology

Consultants In Medical Oncology And Hematology PC

500 Evergreen Dr, Suite G4, 
Glen Mills, PA 
 (18.4 miles away)
610-887-0303
Languages Spoken:
English
See accepted insurances

Robert Roush is a Hematologist Oncology specialist and a Hematologist in Glen Mills, Pennsylvania. Dr. Roush is rated as a Distinguished provider by MediFind in the treatment of Splenomegaly. His top areas of expertise are Colorectal Cancer, Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, and Pleuropulmonary Blastoma.

VIEW MORE SPLENOMEGALY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hexner's expertise for a condition
ConditionClose
  • Elite
  • Acute Myeloid Leukemia (AML)
    Dr. Hexner is
    Elite
    . Learn about Acute Myeloid Leukemia (AML).
    See more Acute Myeloid Leukemia (AML) experts
  • Graft Versus Host Disease (GvHD)
    Dr. Hexner is
    Elite
    . Learn about Graft Versus Host Disease (GvHD).
    See more Graft Versus Host Disease (GvHD) experts
  • Myelofibrosis
    Dr. Hexner is
    Elite
    . Learn about Myelofibrosis.
    See more Myelofibrosis experts
  • Myeloproliferative Neoplasms (MPN)
    Dr. Hexner is
    Elite
    . Learn about Myeloproliferative Neoplasms (MPN).
    See more Myeloproliferative Neoplasms (MPN) experts
  • Polycythemia Vera
    Dr. Hexner is
    Elite
    . Learn about Polycythemia Vera.
    See more Polycythemia Vera experts
  • Systemic Mastocytosis
    Dr. Hexner is
    Elite
    . Learn about Systemic Mastocytosis.
    See more Systemic Mastocytosis experts
  • Distinguished
  • Acute Myeloblastic Leukemia without Maturation
    Dr. Hexner is
    Distinguished
    . Learn about Acute Myeloblastic Leukemia without Maturation.
    See more Acute Myeloblastic Leukemia without Maturation experts
  • Essential Thrombocythemia
    Dr. Hexner is
    Distinguished
    . Learn about Essential Thrombocythemia.
    See more Essential Thrombocythemia experts
  • Leukemia
    Dr. Hexner is
    Distinguished
    . Learn about Leukemia.
    See more Leukemia experts
  • Mast Cell Activation Syndrome (MCAS)
    Dr. Hexner is
    Distinguished
    . Learn about Mast Cell Activation Syndrome (MCAS).
    See more Mast Cell Activation Syndrome (MCAS) experts
  • Advanced
  • Acute Eosinophilic Pneumonia
    Dr. Hexner is
    Advanced
    . Learn about Acute Eosinophilic Pneumonia.
    See more Acute Eosinophilic Pneumonia experts
  • Acute Lymphoblastic Leukemia (ALL)
    Dr. Hexner is
    Advanced
    . Learn about Acute Lymphoblastic Leukemia (ALL).
    See more Acute Lymphoblastic Leukemia (ALL) experts
  • Acute Myeloblastic Leukemia with Maturation
    Dr. Hexner is
    Advanced
    . Learn about Acute Myeloblastic Leukemia with Maturation.
    See more Acute Myeloblastic Leukemia with Maturation experts
  • Acute Promyelocytic Leukemia
    Dr. Hexner is
    Advanced
    . Learn about Acute Promyelocytic Leukemia.
    See more Acute Promyelocytic Leukemia experts
  • Aleukemic Leukemia Cutis (ALC)
    Dr. Hexner is
    Advanced
    . Learn about Aleukemic Leukemia Cutis (ALC).
    See more Aleukemic Leukemia Cutis (ALC) experts
  • Aplastic Anemia
    Dr. Hexner is
    Advanced
    . Learn about Aplastic Anemia.
    See more Aplastic Anemia experts
View All 17 Advanced Conditions
  • Experienced
  • Acute Myelomonocytic Leukemia
    Dr. Hexner is
    Experienced
    . Learn about Acute Myelomonocytic Leukemia.
    See more Acute Myelomonocytic Leukemia experts
  • Adult T-Cell Leukemia
    Dr. Hexner is
    Experienced
    . Learn about Adult T-Cell Leukemia.
    See more Adult T-Cell Leukemia experts
  • Agranulocytosis
    Dr. Hexner is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Anemia
    Dr. Hexner is
    Experienced
    . Learn about Anemia.
    See more Anemia experts
  • B-Cell Lymphoma
    Dr. Hexner is
    Experienced
    . Learn about B-Cell Lymphoma.
    See more B-Cell Lymphoma experts
  • Blood Clots
    Dr. Hexner is
    Experienced
    . Learn about Blood Clots.
    See more Blood Clots experts
View All 30 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.